Projects per year
Personal profile
Education
- 2014-2020 Ph.D., The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2000-2007 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- Attending Physician, Taipei Medical University Hospital
- 2021.01- Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2020.11- Assistant Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
- 2019.08-2020.12 Acting Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2014.04-2015.06 Adjunct Attending Physician, Taipei Medical University Hospital
- 2013.04-2014.09 Adjunct Attending Physician, Landseed International Hospital
- 2012.11-2015.06 Attending Physician, Taipei Municipal Wanfang Hospital
Fingerprint
Dive into the research topics where Hsin-Lun Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
針對缺氧相關因子與緩激肽B1 受體-水通道蛋白4 訊號軸以克服多形性膠質母細胞瘤放射拮抗性之研究
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Stem Cell-Based Approaches and Organotypic Culture System for Dissecting Pathogenic Mechanisms and Establishing Therapeutic Strategies for Inflammatory Bowel Diseases and Gastrointestinal Cancer(3/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
Investigating the Dynamic Change of Genotype and Phenotype in Circulating Tumor Cells and Its Clinical Significance in Cancer Progression
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
利用幹細胞及類器官技術剖析發炎性腸道疾病及消化道癌症的病理機轉並發展治療策略(2/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
A Few-Shot Learning Approach Assists in the Prognosis Prediction of Magnetic Resonance-Guided Focused Ultrasound for the Local Control of Bone Metastatic Lesions
Hsu, F. C., Lee, H. L., Chen, Y. J., Shen, Y. A., Tsai, Y. C., Wu, M. H., Kuo, C. C., Lu, L. S., Yeh, S. D., Huang, W. S., Shen, C. N. & Chiou, J. F., Jan 1 2022, In: Cancers. 14, 2, 445.Research output: Contribution to journal › Article › peer-review
Open Access -
Atypical Teratoid/Rhabdoid Tumor in Taiwan: A Nationwide, Population-Based Study
Liu, Y. L., Tsai, M. L., Chen, C. I., Yar, N., Tsai, C. W., Lee, H. L., Kuo, C. C., Ho, W. L., Hsieh, K. L. C., Tseng, S. H., Miser, J. S., Chang, C. Y., Chang, H., Huang, W. C., Wong, T. T., Wu, A. T. H. & Yen, Y. C., Feb 1 2022, In: Cancers. 14, 3, 668.Research output: Contribution to journal › Article › peer-review
Open Access -
Microtube Array Membrane Hollow Fiber Assay (MTAM-HFA)—An Accurate and Rapid Potential Companion Diagnostic and Pharmacological Interrogation Solution for Cancer Immunotherapy (PD-1/PD-L1)
Huang, W. T., Yun, T., Chew, C. H., Chen, A., Wei, P. L., Lee, K. Y., Lee, H. L., Feng, P. H., Chiou, J. F., Chen, C. M. & Chen, C. C., Apr 2022, In: Biomolecules. 12, 4, 480.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Enhanced platelet-rich plasma (EPRP) stimulates wound healing through effects on metabolic reprogramming in fibroblasts
Weng, H. P., Cheng, Y. Y., Lee, H. L., Hsu, T. Y., Chang, Y. T. & Shen, Y. A., Dec 1 2021, In: International journal of molecular sciences. 22, 23, 12623.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Ex vivo expanded circulating tumor cells for clinical anti-cancer drug prediction in patients with head and neck cancer
Lin, K. C., Ting, L. L., Chang, C. L., Lu, L. S., Lee, H. L., Hsu, F. C., Chiou, J. F., Wang, P. Y., Burnouf, T., Ho, D. C. Y., Yang, K. C., Chen, C. Y., Chen, C. H., Wu, C. Z. & Chen, Y. J., Dec 1 2021, In: Cancers. 13, 23, 6076.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)
Datasets
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606698/1
Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM2_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606662/1
Dataset
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://figshare.com/collections/Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/3931717/1
Dataset
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, Nov 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606626/1
Dataset